Long-term low-dose erythromycin in patients with unexplained chronic cough: a double-blind placebo controlled trial.

Long-term low-dose erythromycin in patients with unexplained chronic cough: a double-blind placebo controlled trial.

AIMS: Unexplained chronic cough is a common condition with no satisfactory treatments. Previous work has suggested that cough may be linked to neutrophilic airway inflammation. This study tested the hypothesis that long-term low-dose erythromycin reduces the induced sputum neutrophil count and 24 h...

Bibliografski detalji
Glavni autori:	Yousaf, N, Monteiro, W, Parker, D, Matos, S, Birring, S, Pavord, I
Format:	Journal article
Jezik:	English
Izdano:	2010

Slični predmeti

The long term outcome of patients with unexplained chronic cough.
od: Yousaf, N, i dr.
Izdano: (2013)

Cough frequency in health and disease.
od: Yousaf, N, i dr.
Izdano: (2013)

Theobromine for the treatment of persistent cough: a randomised, multicentre, double-blind, placebo-controlled clinical trial
od: Morice, A, i dr.
Izdano: (2017)

Cough
od: Birring, S, i dr.
Izdano: (2012)

Cough
od: Birring, S, i dr.
Izdano: (2008)

An automated system for 24-h monitoring of cough frequency: the leicester cough monitor.
od: Matos, S, i dr.
Izdano: (2007)

Montelukast for postinfectious cough in adults: A double-blind randomised placebo-controlled trial
od: Wang, K, i dr.
Izdano: (2014)

Montelukast for postinfectious cough in adults: a double-blind randomised placebo-controlled trial
od: Wang, K, i dr.
Izdano: (2014)

Montelukast for postinfectious cough in adults: a double-blind randomised placebo-controlled trial.
od: Wang, K, i dr.
Izdano: (2014)

Montelukast for postinfectious cough in adults: a double-blind randomised placebo-controlled trial
od: Wang, K, i dr.
Izdano: (2013)

The assessment of quality of life in acute cough with the Leicester Cough Questionnaire (LCQ-acute).
od: Yousaf, N, i dr.
Izdano: (2011)

The Leicester Cough Monitor: preliminary validation of an automated cough detection system in chronic cough.
od: Birring, S, i dr.
Izdano: (2008)

Cough frequency, cough sensitivity and health status in patients with chronic cough.
od: Birring, S, i dr.
Izdano: (2006)

Four-hour cough frequency monitoring in chronic cough.
od: Lee, K, i dr.
Izdano: (2012)

Chronic cough and gastro-oesophageal reflux.
od: Birring, S, i dr.
Izdano: (2004)

Efficacy of Erythromycin in treatment of pityriasis rosea (A double-blind, placebo-controlled clinical trial)
od: Mohammad Dehghan, i dr.
Izdano: (2008-04-01)

Leicester Cough Questionnaire validation and clinically important thresholds for change in refractory or unexplained chronic cough
od: Allison Martin Nguyen, i dr.
Izdano: (2022-05-01)

Cough and asthma.
od: Berry, M, i dr.
Izdano: (2003)

Idiopathic chronic cough and organ-specific autoimmune disease.
od: Birring, S, i dr.
Izdano: (2006)

Detection of cough signals in continuous audio recordings using hidden Markov models.
od: Matos, S, i dr.
Izdano: (2006)

A longitudinal assessment of acute cough.
od: Lee, K, i dr.
Izdano: (2013)

Assessment of gender differences in health status with the Leicester Cough Questionnaire (LCQ).
od: Birring, S, i dr.
Izdano: (2009)

A phase 3, randomized, double-blind, clinical study to evaluate the long-term safety and efficacy of gefapixant in Japanese adult participants with refractory or unexplained chronic cough
od: Akio Niimi, i dr.
Izdano: (2022-10-01)

Management of chronic unexplained cough
od: Mohamed S Al-Hajjaj
Izdano: (2017-01-01)

Rationale and design of two, phase 3, randomized controlled trials (COUGH-1 and COUGH-2) of gefapixant, a P2X3 receptor antagonist, in refractory and unexplained chronic cough
od: David Muccino, i dr.
Izdano: (2020-08-01)

Unexplained disabling and long-lasting cough: a case report
od: Francesco Ferrante, i dr.
Izdano: (2024-12-01)

Design and rationale of two phase 3 randomised controlled trials (COUGH-1 and COUGH-2) of gefapixant, a P2X3 receptor antagonist, in refractory or unexplained chronic cough
od: David R. Muccino, i dr.
Izdano: (2020-11-01)

Effect of Erythromycin on Orocecal Transit Time in Normal Healthy Male Subjects: A Double-Blind, Placebo Controlled Study
od: Anil Minocha, i dr.
Izdano: (1995-01-01)

Content validity of the Leicester Cough Questionnaire in adults with refractory or unexplained chronic cough: a qualitative interview study
od: Allison Martin Nguyen, i dr.
Izdano: (2024-09-01)

Induced sputum inflammatory mediator concentrations in chronic cough.
od: Birring, S, i dr.
Izdano: (2004)

A double-blind randomised placebo-controlled trial investigating the effects of lesogaberan on the objective cough frequency and capsaicin-evoked coughs in patients with refractory chronic cough
od: Huda Badri, i dr.
Izdano: (2022-03-01)

The objective assessment of cough frequency in bronchiectasis
od: Spinou, A, i dr.
Izdano: (2017)

Obstructive sleep apnoea: a cause of chronic cough.
od: Birring, S, i dr.
Izdano: (2007)

Prevalence of refractory and unexplained chronic cough in adults treated in cough centre
od: Paweł Kukiełka, i dr.
Izdano: (2024-09-01)

Chronic tonsillar enlargement and cough: preliminary evidence of a novel and treatable cause of chronic cough.
od: Birring, S, i dr.
Izdano: (2004)

Development of a symptom specific health status measure for patients with chronic cough: Leicester Cough Questionnaire (LCQ).
od: Birring, S, i dr.
Izdano: (2003)

Erythromycin for myotonic dystrophy type 1: a multicentre, randomised, double-blind, placebo-controlled, phase 2 trialResearch in context
od: Masayuki Nakamori, i dr.
Izdano: (2024-01-01)

The effect of pheniramine on fentanyl-induced cough: a randomized, double blinded, placebo controlled clinical study
od: Zakir Arslan, i dr.
Izdano: (2016-07-01)

The effect of pheniramine on fentanyl-induced cough: a randomized, double blinded, placebo controlled clinical study
od: Zakir Arslan, i dr.

Improvement in health status following cough-suppression physiotherapy for patients with chronic cough.
od: Patel, A, i dr.
Izdano: (2011)